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Abstract—Most of the time, complete adherence to prescribed medication is 
a big step towards recovery from either chronic or acute diseases, but patients 
often are unaware of the adverse effects that could arise from inconsistency in 
adherence. The inability of patients to adhere to prescription can affect the po-
tency of some effective therapies known to treat many conditions, and passive 
compliance may result in the development of resistant to the drug causing a 
need for treatment modification. Shockingly, more than half of the drugs pre-
scribed for patients with chronic conditions like diabetes and hypertension were 
found not to be taken as recommended. Adherence is so important because it 
can assist clinicians in successful supervision of evidence-based treatment of 
patients; therefore this paper presents an overview of medication adherence, 
non-technology and technology-based approaches, and lessons for developing 
countries. 
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1 Introduction & Background 
Medication adherence is an important step in the treatment of diseases, and pa-
tients’ inconsistencies to the regimen could result in a poor state of health, unneces-
sary increased cost of care, and long recovery time. Nonadherence has been recog-
nized as a public health issue in both developed and developing countries, although 
evaluating nonadherence could be expensive in countries with decentralized 
healthcare system [1,2]. Moreover, Africans and Asians have been found to be more 
non-compliant with medication regimens [3]. Due to different reasons, patients might 
decide against collecting their prescribed medications from the dispensing system, 
resort to overdose, and indulge in irregular intake frequency. These kinds of primary 
noncompliance which slow down recovery, though can be reduced to some extent by 
the use of technology in prescription, are very common in rural areas of developing 
countries [4]. Factors such as education, gender, and proximity and frequency of visit 
to healthcare facilities have been identified to be responsible for noncompliant 
behaviour towards electronic prescription in poor countries [4]. 
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As stated in existing studies, low level of medication adherence is connected with 
many things such as the high possibility of demise and hospitalization of people with 
heart failure with reduced ejection fraction[5], exposure to a high risk of sudden frac-
tures and deaths in osteoporosis patients[2], and several other casualties. Nonadher-
ence is chiefly high among patients with chronic diseases, especially hypertensive 
patients who are responsible for close to 50% of nonadherence, and by the year 2025, 
the prevalence of hypertension is projected to go up by 30% [3]. The direct and indi-
rect methods have been used for evaluating drug adherence It is however recommend-
ed that the use of direct methods for treatment of chronic disease, like resistant hyper-
tension, is more accurate and less prone to patients’ manipulation [6]. Direct methods 
make use of direct observation of the patient in the course of taking the prescription, 
and therapeutic drug monitoring. The indirect methods analyzing medication adher-
ence include the use of adherence questionnaire, medical diaries, patient interviews, 
automated electronic pillbox, prescription registries, and manual counting of pills [1]. 
Using Morisky Green Levine Questionnaire, a study on adherence performed with 
150 patients taking medication for at least two chronic conditions showed that 52% of 
the patients were non-adherent with associated causes including forgetfulness which 
occurred in 43.3% patients, carelessness (20%), discontinuing medication once pa-
tients felt better (14.7%) and stopping the medication once they felt worse (13.3%). It 
was also shown that 48.7% were unintentionally non-adherent, 24% were intentional-
ly non-adherent, and 20.7% had mixed attitudes towards adherence [7]. In addition to 
the myriad of other factors such as medication intolerance, the need for support, the 
cost of treatment, and forgetfulness; insufficient motivation is equally responsible for 
non-adherence to medication exercise [8]. Inadvertent negligence of patients, proba-
bly arising from low motivation, is reported to be associated with about one-third of 
medication noncompliance, and a lot of smartphone apps have been designed to this 
effect, though with most focusing more on deliberate nonadherence, and with many 
lacking shreds of evidence that showed neither their effectiveness nor quality. There 
are indications that even many of the people who take their medication regimens seri-
ously also fall victim of forgetfulness. Apart from gamifying adherence process by 
introducing game elements to add fun, and modify and train the psychology of the 
patients [8], one of the interesting general solutions to tackle this is the formalization 
of the guidelines for designing apps for reminding patients about their medication 
routine developed by [9]. Rather than relying solely on generic timer-based medica-
tion reminders, the amalgamation of daily routine actions and habits like breakfast, 
visiting the kitchen and other things done regularly into reminder apps was advocated 
for. This association is expected to reduce the burden of trying to catch up with ordi-
nary difficult timer task and makes the process smarter and more personalized. None-
theless, different forms of technologies to assist patients such as the reminder app 
have been proposed, however an evaluation of technology meditated interventions 
(TMIs) for supporting adherence from Cochrane review showed that, even though 
TMI has been used for providing patients with health education, professional advice, 
personal health management tools, and reminders, evidence supporting TMI for ad-
herence is still limited and inconsistent [10]. 
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Globally, the use of technology in healthcare service delivery (known as eHealth) 
has the potential to transform healthcare medications management, by providing im-
portant personalization and tracking– which can help to reduce the overhead cost 
associated with fluctuating abidance to medication instructions. [11,12,13]. [11] in-
vestigated the projected roles of eHealth systems in supporting and improving the 
general health of patients and the effectiveness of adherence as medication interven-
tion. They concluded in order for low- and middle-income countries to benefit from 
the future eHealth solutions, there is a need for a context-based and adaptable trans-
disciplinary research approach that considers the multifaceted factors that can con-
tribute to effective investment in eHealth at the macro, micro, and meso levels. 
Whether the pieces of evidence supporting technology usage are conflicting or not, it 
is difficult to categorically undermine the role of technology in improving medication 
adherence, and some studies have even stated that the use of telemedicine technology 
for medication adherence and the future exploration of artificial intelligence can also 
change the way medication regimens is addressed [14]. This paper performs a sum-
mary review of medication adherence, non-technology and technology-based ap-
proaches, and a lesson for developing countries. 
2 Literature Review 
Recapitulation of some of the related work pertaining to adherence in different 
groups of patients is presented in this section. Medication adherence issue is common 
among patients treating both chronic and acute diseases irrespective of their age 
group. Medication adherence challenges facing elderly patients were presented in [15] 
through the case report of a certain 80-year-old male patient who could not manage 
his 17 different medications at home. In their findings, the elderly are susceptible to 
several comorbidities requiring polypharmacy, and this may make them guiltier of 
medication nonadherence that younger patients. They are therefore likely to have a 
more frequent hospitalization, increased health spending, slow healing and so on. 
Similar to the hurdles in the way of older adults’ commitment to medication regimens 
stated in [16], the authors divided the factors responsible for elderly nonadherence 
into five – patient, socioeconomic, healthcare system, healthcare provider, and medi-
cation. They concluded by emphasizing that the job of a physician does not stop at 
writing a prescription alone, but it also includes ensuring patients’ adherence so that 
they can maximize benefits therapeutically. According to [2], the level of nonadher-
ence in osteoporosis patient is comparable to what is found in other chronic diseases 
like diabetes and hypertension. Osteoporosis medication has been proven to work 
well, however, nonadherence could be dangerous because a noncomplying patient 
may show no symptoms until a fracture occurs. Similarly, they also stressed the need 
to understand some of the contributing factors to nonadherence mentioned in [15]. 
Healthcare system interventions such as pharmacist-directed interventions and frac-
ture liaison service appeared to be successful. Patient-directed behavioural interven-
tions such as behavioral interventions using counseling sessions, and behavioral inter-
ventions using prompts for taking medications (use of pillbox, calendars, alarm 
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clocks, telephone calls and so on) did not give a good outcome. They concluded that 
the lack of awareness and poor education of patients on osteoporosis may have con-
tributed to the failure of patient-directed behavioural intervention. The most frequent-
ly used interventions for enhancing medication compliance identified by [17], were 
classified as behavioral interventions (therapies and techniques to improve patients’ 
attitude to treatment), educational intervention (patients’ education on medication 
adherence techniques), integrated care interventions (collaborations between health 
care personnel and patients), self-management and risk communication interventions. 
It was also noted that many studies focused on short term adherence, and the adher-
ence methods in place for chronic patients have not been very effective. The authors 
concluded that behavioral adherence interventions have been more successful than 
others, suggesting a need for more focus on improving health literacy. [18] carried out 
a review of medication adherence in patients with chronic heart failure (CHF). The 
search was performed using Medline and Cochrane database and incorporated all 
records accessible up until 2014. It yielded 17 studies that covered 162,727 patients. 
Ten studies which covered 33.7% of all participants showed no correlation between 
age and medication adherence, and the mean age of adherent patients was between 66 
and 75 years of age. Only one study indicated a better medication adherence in older 
patients compared to youths and they then concluded that increased age alone is not 
connected to reduced medication adherence in patients with CHF. A cross-sectional 
study was carried out with 2445 adult patients on an anti-hypertensive medication by 
[19] in Hong Kong. A questionnaire was used and eight-item Morisky medication 
adherence scale was applied to evaluate the level of adherence in these patients. Re-
sults from their study demonstrated that about 55.1% of the patients had good medica-
tion adherence, with a score greater than 6. Age, employment status, illness percep-
tion, and self-perceived health state are viewed as basic factors in medication adher-
ence. They concluded by suggesting the use of educational projects in promoting 
adherence in younger patients. Understanding the factors affecting adherence is still 
ongoing research because their comprehension can help to increase patient’s compli-
ance. In a recent study, [20] developed a new way to measure medication adherence 
which involves determining adherence levels as well as the specific factors that influ-
ence non-adherence in patients with inflammatory bowel disease. This new method 
called the medication adherence index was evaluated against the popular Morisky 
medication adherence scale-8. It was noted that specifying the reasons for non-
adherence significantly increased adherence in patients, this is logical because if the 
causes of non-adherence are known, adequate solutions can be provided. 
On the impact of mobile technology on adherence, [21] analyzed various mobile 
phone applications for medication adherence, available on Apple and Android devic-
es. Out of the 70 applications identified, 20 applications were assessed through a web-
based review, and a content analysis was done on the reviews provided by users of the 
applications. Apple had a total of 443 adherence applications and Android had 261 
applications. It follows that 38.1% and 31.4% of the Apple and Android applications 
respectively had at least 2 medical adherence features. Also, 17.9% and 33.1% of 
applications on Apple and Android platforms had an alerting or reminder feature and 
over 90% do not require internet connectivity to be able to do so. In the reviews pro-
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vided by users, 34.16% provided positive comments about the adherence applications 
and found them very helpful. In the same vein, [22] performed a review on technolo-
gies available for monitoring medication adherence and categorize them into sensor 
systems, vision-based, proximity-based and fusion based systems. Under sensor sys-
tems, there are wearable sensors and fixed sensors (which can be mounted on pillbox-
es) and ingestible sensors. Some applications in this category include Medtracker, 
Pillsense, and Medrem. MyTmed, which has ingestible biosensors, is an example of 
ingestible sensors. Proximity sensors include technologies that make use of RFID 
technology, vision-based systems include technologies that make use of the 
smartphone camera in detecting medication compliance, and fusion based systems 
blend multiple techniques. Challenges that affect the use of the technologies high-
lighted include, system and data accuracy, energy consumption, acceptability and user 
tampering. [23] identified the most popular technologies for medication adherence, in 
young adults with sickle cell disease through a survey carried out on 80 patients, and 
it was discovered that 79% of patients preferred daily text messages as reminders to 
take medication and other technologies that assist directly observed therapy. The 
major features in smartphones that boost adherence include medication reminders, 
medication logs, positive feedback and adherence text prompts. However, a review of 
15 applications available for HIV management showed that while the majority of the 
applications had reminders, logs, resources and search functionalities, none of them 
had the self-management feature which is necessary for persons living with HIV. 
Authors in [24] further investigated software solutions and computerized devices 
accessible for improving heart failure results by conducting a survey on mobile appli-
cations available for medication adherence. Key highlights of the applications were 
presented and many of the mobile applications have an interactive education module 
and social support networks which help enhance disease management. A precedent, 
Proteus Discover: a mobile application with a versatile sensor patch that reports the 
pulse, blood pressure and medication adherence of patients to sensor enabled pills was 
mentioned. Other applications include Medisafe, Pill monitor free, and Dosecast. The 
authors recommended the use of digital and patient management tools for a robust 
heart failure platform for enhancing adherence. [25] examined the perception of hy-
pertensive patients to the use of smartphone applications in improving adherence in a 
study with 24 participants. The application analyzed, MiBP, is a self-management 
application for hypertension that helps remind users to take medication, monitors, and 
reports blood pressure of users. Interactions with users showed a willingness to use 
smartphone applications for self-management of hypertension though some users had 
doubts about the continued use of the application for a long period of time. [26] ana-
lyzed the level of adherence in patients using an electronic medication dispenser 
(EMD). A randomized study was carried out for a year, on patients’ compliance in 
taking immunosuppressive medication. The EMD can relay video and audio signals to 
notify users of the prescription time to take the medication. The signal is repeated for 
over an hour and then a report is forwarded to the web portal whether the patient is 
compliant or not. Results showed the EMD achieved an adherence rate of 97.8% and 
missed doses was common in younger patients. The study also informed that 50% of 
patients tend to forget evening doses more often than a morning dose of medication. 
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Many of the proposed electronic detection monitoring devices (EMD) for inhaler 
adherence in asthma patients have only been implemented for clinical research and 
[27] investigated the impact of EMD’s based on cost-effectiveness, feasibility, and 
barriers in a variety of settings to encourage the use of EMD in a larger population. 
Some EMDs for inhaler adherence considered are Asthmapdis (which has a mobile 
application and a tracking device on the inhaler), Doser (which records the total num-
ber of puffs per day), smart inhaler tracker, Akita, and so on. The major limitations of 
the devices are the cost of devices, data transfer and vulnerability to changes in the 
inhaler design. It was noted that EMD technologies for inhaler adherence by direct 
patient reminder or clinician to patient feedback are most promising and can improve 
medication adherence. The world’s aged population is increasing rapidly; another 
study on medication adherence in the elderly was carried out by [28]. They proposed 
the use of a pervasive multimedia system that takes advantage of multimedia technol-
ogy customization features to improve compliance in home health care. Multimedia 
system that can adapt to the surrounding of the elderly by rendering a context-aware 
prompt using audio, text, images or animations correctly and appropriately can sup-
port home care adherence. Services provided by their system include the ability to 
follow medication plan online, medication advice, identification of medication infor-
mation and so on. The evaluation result of their developed system showed great prom-
ises in enhancing adherence among the aged.  
In a nutshell, a lot of reminder apps existing in the market have been discussed 
elaborately in past works, but recently, [29] examined the effect of reminder devices 
on patients between 18 and 64 years taking more than 1 medication. The study was 
conducted for a 2-year period amongst 53480 patients. Medication possession ratio 
(MPR) was used to assess adherence; patients with MPR value greater the 80 were 
considered optimally adherent and MPR value between 30 and 80 are suboptimal 
adherent. It was shown that about 16% of patients were optimally adherent and the 
conclusion was that the reminder devices did not necessarily improve the level of 
adherence in non-adherent patients. On the contrary, [30] evaluated the use of 
mHealth in reminding patients with coronary heart disease to take medication. Using 
applications like Wechat and BBreminder, and a survey carried out on 50 patients for 
a 30-day period and finding showed that medication adherence was improved in the 
experimental group. Therefore, it is dicey to generalize either the effectiveness or 
non-effectiveness of reminder apps. Nevertheless, overall total compliance to medica-
tion regimens is beneficial, for example as of 2011, [31] analyzed the relationship 
between medication adherence and cost of healthcare including medications. Their 
study included data from 16,353 patients with congestive heart failure, 112,757 hyper-
tensive patients, 42,080 diabetic patients and 53,041 patients with dyslipidemia. The 
MPR was used to measure adherence and medical costs obtained from patients claims. 
The patients with congestive heart failure had the lowest MPR value of 0.40 and the 
hypertensive patients had the highest MPR value of 0.59 while the total cost per pa-
tient was an average of $39,076 for patients with cognitive heart failure and $14,813 
for hypertensive patients. It was shown that in the long run, the annual cost was 
smaller in adherent patients. They concluded that medication adherence though in-
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creases pharmacy costs reduces the total costs of healthcare and medications. Some of 
the specific recent technologies developed for adherence are described in Table 1. 
Table 1.  Some of the technologies used for adherence  
Author Application Description Technology 
[32] TransplantHero: A mobile application with a smartwatch for medication adher-
ence. The application is used to remind patients and provide helpful contents. 
Their evaluation focused on users > 18 years and was carried out on 108 patients. 
19% of patients used both the smartwatch and application whereas 35% used the 
mobile application alone. It was concluded that the use of the mobile application 
or smartwatch did not increase medication adherence levels as compared to users 
who did not use either of them. 
Smartwatch for 
medication 
adherence 
[33] WiseApp: A mobile self-management health application for patients living with 
HIV. The application monitors patients’ adherence in real-time and contains 
features like medtrackers, push notifications, testimonial videos from persons 
with the same condition, health surveys and a schedule of health-related tasks for 
each day. WiseApp was evaluated amongst 20 users with a mean age of 51.3 
years. The health information technology usability evaluation scale used to 
assess adherence level showed that the application is usable and useful 
Self-
management 
health app /HIV 
[34] A smart prescription packaging to combat issues with general pharmaceutical 
packages used. Some of the challenges addressed are the difficulties in gauging 
how much medication is left and an appropriate reminder to suit the elderly. The 
smart packaging system has key features that include a light sensor to detect 
when the medication pack is opened, a reminder application that also confirms if 
medication is taken, an alarm to warn finished medications which should be 
refilled and Bluetooth functionality that transfers prescription data to mobile 
devices. Evaluations reported positive feedback from users and the system can be 
combined with other packaging technologies. 
Smart prescrip-
tion 
[35] Smart Assist: a smartphone intervention based on augmented reality for propa-
gating drug adherence in patients with special needs and the elderly. The applica-
tion is user-friendly and makes use of the smartphone camera in detecting medi-
cations. It has a three-layer framework which namely - patient-drug interface 
with cloud integration, a pharmacy vendor management, and clinician site. The 
application connects to the patient medical record and then images of the drug, 
the drug dose frequency and a presentation on how the drug should be adminis-
tered were shown on the users’ device. The application also recognizes when the 
drug is taken, that is, after the user scans the drug with the computer vision 
feature, then the system updates the drug chart. The pharmacy vendor stage 
provides details of the drug and its vendors, and the clinical administration 
allows medical staff to access the application and set reminders or monitor their 
patients. 
Smartphone 
intervention 
[36] MEDIBOX: a portable intelligent device for improving medication adherence. 
The device has sensors to track the temperature and humidity and avoid depre-
ciation of the medication stored in the box. It also has a cooling system and 
power supply. It can store a patient’s information such as discharge summary and 
other information on the cloud.  
A portable 
intelligent 
medication 
monitoring 
device 
[37] A smart medication cabinet system to monitor adherence in elderly patients. This 
medicine cabinet has an alarm system that goes off when it is time to take the 
medication and a sensor that detects if the cabinet is opened which deactivates 
the alarm. The system is also able to send a report of medication compliance to 
friends and family members of the patient. 
Smart medica-
tion cabi-
net/elderly 
[38] Ambupod: A mobile ambulance outpatient department in India. This technology 
is cost effective and capable of taking blood, urine, blood samples, checking 
sugar levels and pulse. It is a telemedicine device that is video-enabled and sends 
the patients medication details to their respective doctors. Though the Ambupod 
is not for e-prescription, it can be modified to perform medication adherence. 
Mobile ambu-
lance 
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[39] A smart transportation IOT based system for transporting pharmaceutical medi-
cation. The system keeps cloud information on the transportation location 
through GPS, at regular intervals, has a transportation box with RFID which can 
read product data and a transportation box which can only be opened when the 
box is close to the customers’ location earlier given. The system is also able to 
monitor and report traffic jam within every 2 kilometers and provide alternative 
routes. It also has the alarm feature to remind patients to take prescribed medica-
tion. The system is reported to be cheap and efficient, and it has an anti-fraud 
feature for security 
Smart medica-
tion transporta-
tion 
[40] AICure: an AI platform installed on mobile devices, for monitoring medication 
adherence. Prior methods available for monitoring adherence include the use of 
pill counts and self-reported data, electronic monitoring packages - which are 
reliable but do not verify drug administration - and, the direct-observed-therapy 
(DOT) - which is a very intensive method for monitoring non-adherence but very 
effective. However, AICure visually identifies the patients using facial recogni-
tion and algorithms to confirm ingestion of the prescribed medication. The 
platform was evaluated in a six-month study on 53 subjects, out of 431 schizo-
phrenia patients who were participating in a phase 2 clinical study of ABT-126 
medication. Results showed that subjects using the AICure platform were 25% 
more adherent compared to subjects monitored with the modified DOT.  
AI platform for 
monitoring 
adherence/ 
schizophrenia 
[41] Video / virtually observed therapy (VOT): a technology for monitoring medica-
tion adherence in tuberculosis patients. It takes advantage of the Internet connec-
tivity and video conferencing capabilities of smartphones. Since smartphones are 
now readily available in low- and middle-income countries, therefore the VOT 
has great potentials. The VOT has been successfully deployed in London and 
eastern Europe. 
Virtually ob-
served therapy/ 
tuberculosis 
[42] ScanMed: an application for tracking medication adherence. The system has a 
web interface for the healthcare professional and a mobile interface for patients 
use. The health professional is able to input all medication details on the inter-
face and a QR code which contains the information is printed on the medication 
container. The mobile application acquires the information after it is scanned and 
displays the information on the user’s mobile device. The application reminds 
and notifies the user’s when it’s time to take the medication. However, the user is 
required to scan the medication each time he or she is compliant, as a proof of 
adherence but it is argued that this technique may not guarantee adherence. 
Mobile medica-
tion tracker 
[43] A smartwatch-based medication adherence solution that measures a patient’s 
adherence when using gel capsule medications. The watch utilizes sensors in 
capturing users’ actions, a triaxial accelerometer and a gyroscope. The motions-
captured-as-data in measuring adherence by the smartwatch were the cap of the 
bottle being turned and the wrist being turned with the palm facing upwards. The 
two motions must occur consecutively to affirm ingestion by the watch. The 
technology is evaluated on 12 subjects and the application had a 30% precision 
in the medication bottle opener gesture and 82.7% precision in detecting palm up 
gestures. 
Smartwatch-
based medica-
tion adherence 
system 
[44] A drug checker system based on IOT to monitor drug adherence and detect 
adverse drug reactions. The application can be installed on smartphones and 
PDAs. The drugs to be taken can be verified using a pharmaceutical intelligent 
information system (PIIS) and patient’s information obtained from a personal 
health record, PIIS database or personal health card based on RFID. Once the 
information is acquired, an intelligent system detects and reports drug allergies, 
interactions, side-effects and optimized times for drug consumption. 
Drug checker 
system 
[45] UbiMeds: a mobile application for improving medication adherence in the elder-
ly and disabled with visual and cognitive impairment. It is easily accessible, 
provides details of medication to be taken, allows physician-patient monitoring, 
automated reminders, and text to speech features. It integrates with the patient’s 
personal health record, tracks prescription intake, and notifies the patient’s 
family and physician when the patient is non-compliant. However, the applica-
tion was designed to run only on Apple devices. 
Multimedia 
medication 
Adherence 
monitor 
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3 Methodology and Implications 
Over 70 articles were used in this study and our articles were mainly downloaded 
from Google Scholar, Science Direct and PubMed databases. Our search emphasizes 
on technology in adherence and general medication adherence challenges. The distri-
butions, by year, of some of the selected 65 articles considered in this study are shown 
in Figure 1. Since there are different schools of thought on the sustainability of tech-
nology supporting medication adherence, especially those involving reminder apps, 
we highlighted some of the technologies and applications found in our review. Data in 
Table 2 shows some of the Information and Communications Technology (ICT) ap-
plications that have been revealed to somehow influence medication adherence. Even 
though many of the studies were carried out and implemented outside the shores of 
Africa and the like, some of them are viable solutions that can be adopted. It goes 
without saying that technology has a promising potential at improving medication 
adherence but some of the limiting factors contributing to non-adherence can be a cog 
in the wheel, and some of those challenges found in our review are shown in Table 3, 
with the frequency of their appearance and some possible solutions. Since identifying 
reasons for non-adherence can significantly increase adherence, and therefore aid in 
providing adequate solutions [20]; forgetfulness and cost are still chief among the 
global leading factors.  
Diseases such as cardiovascular diseases, asthma, and diabetes were the top rank-
ing diseases largely referenced in many of the work we reviewed and are likewise 
prevalent in developing countries like Africa. The spread of these diseases in develop-
ing countries and implications are scary, therefore, use of existing technological solu-
tion supporting adherence is important. 
Diabetes is a risk factor of cardiovascular diseases and when left untreated causes 
a lot of complications. In developing countries, between 1980 and 2015, there have 
been 88% increases in the number of diseases attributed to diabetes with over 90% 
cases associated with type2 diabetes. Also, within this period, the number of adults 
with diabetes increased drastically from 108 million to 422 million. Common causes 
of type2 diabetes are overweight and obesity, which can be associated with poor feed-
ing habits by individuals in low middle-income countries [46]. Only 25.8% of coun-
tries have adopted guidelines for managing hypertension. 
Hypertension is the most common cause of renal dysfunction and chronic kidney 
diseases which is a major health burden [47].  
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Fig. 1. Article distribution by year 
Table 2.  Some of the technologies used for adherence 
Technology Author Impact 
Asthma adherence pathway (AAP) [48] Positive 
Medsimple (Medication management application) [49] Positive 
Remotely monitored therapy [50] Positive 
Tablet technology [51] Positive 
TransplantHero (Mobile app for education and reminder) [32] Positive 
Interwalk smartphone app [52] Positive 
Self-management app [33] Positive 
Mhealth technology [53] Positive 
mKidney system [54] Not evaluated 
99DOTS (digital patient management)  [55] Not evaluated 
Electronic pill bottles [56] Positive 
Home-based telehealth group intervention [57] Positive 
Medication monitors, video observed therapy, SMS reminders. [58] Positive 
Medication Event Monitoring Systems (MEMS); Home telemonitoring [59] Positive 
Digitally enabled heart failure management platform (proposed) [24] Not evaluated 
Medibox (a portable intelligent device for pill storage with reminders and alerts 
the physician) [36] Positive 
Smartphone app reminder and self-monitoring; Smart Assist [25], [35] Positive 
Smart medicine cabinet monitoring system [37] Positive 
Gamification [8] Not evaluated 
Ingestible biosensor medication [60] Not evaluated 
Smart medicine transportation and medication monitoring system [39] N/A 
Reminder devices (Pillbox) [29] No effect 
AiCure (Monitoring adherence) [40] Positive 
Video-enabled devices for patient-healthcare professional interaction [41] Not evaluated 
Apps with reminders, text prompts, education on medication and medication log 
features [23] Positive 
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E-prescription apps [61] Positive 
ScanMed (Medication tracker and reminder) [42] Positive 
Smartwatch based monitoring system [43] Positive 
Electronic monitoring drug dispensing device [26] Positive 
Smart pharmaceutical packaging with graphics e-paper [1], [34] Positive 
Reminder and tracking app [9], [21] Positive 
Personal health care device (Movital) [44] Positive 
Electronic monitoring device [27] Positive 
Electronic blister packs [62] Not evaluated 
Health information technology using interactive voice recognition [63] Positive 
Multimedia healthcare system (MHS) [28] Positive 
E-health system [64] Positive 
Daily text reminders [65] No effect 
Table 3.  Factors that affect medication adherence 
 Factors Occurrence Possible solutions 
1 Forgetfulness on the dose and time to take medication 15 Use of automated reminders and smart packages. 
4 High out of pocket medica-tion costs 11 
Health insurance plans; 
Higher priority to low-income areas. 
7 No follow-up by health physicians and family 9 
Directly observed therapy and therapeutic drug monitor-
ing; More supportive patient-provider relationships and 
frequent follow-ups. 
14 Number of pill doses 7 Minimizing pill dose 
10 Complexities (in drug dose) 7 Minimizing the number of pills; Reducing the frequency of drug administration 
5 Harmful side effects 7 
Enlightening patients through education on common side 
effects and ways to prevent them can help to attenuate the 
trepidation and concerns about adverse drug reactions; 
Emphasis on the need for treatment by physicians. 
18 Age-related 6 Easy to use technologies and reminders. 
9 Lack of awareness of availa-ble reminder technologies 5 Counselling and patient education 
13 Changes in treatment sched-ule or drug dosage 5 
Fixed-dose combination therapies; Minimizing changes in 
treatment schedule and follow-ups. 
3 Gaps in medical knowledge 4 Involving pharmacist in medication management; Provision of clear medication knowledge by physicians. 
12 
Difficulty in transportation or 
pickup of medication from a 
pharmacy 
4 E-prescribing 
2 Lack of motivation 3 Pharmacist-delivered counseling; Risk communication; Video observed therapy. 
8 
Lack of digital competence 
or interest in using medica-
tion technologies 
3 Education and coaching  
11 Lack of income or health care insurance 3 
Health insurance plans; Prescription of cost-saving generic 
medication.  
19 Ambiguous medication technologies  3 Introduction of simplified, easy to use technologies. 
15 Self-perceived health status 2 Telephone-based medication counselling  
20 Sustainability (long term use of the technologies for self- 2 
Integration of medical regimen into patients’ routine daily 
activities; 
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management) 
6 Low conscientiousness 1 Evidence-based interventions like educational programs. 
16 Depression 1 Counselling; Providing physiological support. 
17 Impaired cognition 1 Use of technologies with diverse sensors (e.g. text to speech) 
21 
Fear that reminders would 
become annoying over time 
Admitting to relatives that 
their memory is poor causes 
them to refuse medication 
reminders. 
1 Pillboxes; Assistance from caregivers; Self-management technologies. 
 
Chronic kidney diseases have been reported to be 13.9% overall prevalent in sub-
Saharan Africa and primary hypertension is its major risk factor. Some hypertension 
related factors include alcohol and tobacco use, salt intake and lack of physical activi-
ty. For instance, in Uganda, alcohol is reported to be associated with a 64% increased 
risk of developing hypertension [66]. 
Cardiovascular diseases caused an estimate of 17.7 million deaths worldwide in 
2015. Of these deaths, approximately 7.4 million were as a result of coronary heart 
disease and stroke was responsible for about 6.7 million. Also, three-quarters of the 
occurrence of this disease occurs in low middle-income countries and it is the leading 
cause of death globally occurring mostly in those aged greater than 70 years [67]. 
Heart failure is a growing issue in Africa and about 75% of heart failure patient 
cases where non-ischemic in origin and highlights hypertension as a rising cause of 
heart failure. The causes of heart failure such as rheumatic heart disease and endomy-
ocardial fibrosis are more prevalent in Africa. Appropriate therapies and medicines 
for patients with heart failure are unaffordable by 60% of low-income countries as 
seen by the prospective urban rural epidemiology study [68].  
Asthma [69] reported that about 235 million people are suffering from asthma and 
over 80% of deaths resulting from asthma occur in low middle-income countries. It 
was also shown that severe asthma is prevalent among 13-14 years old and the cost of 
asthma medication is out of reach for most patients. Asthma is most prevalent in 
South Africa with a 53% occurrence in children of 5-12 years. In Africa, over 94.8 
million cases of asthma were reported in 2000 and this increased significantly to 
119.3 million in 2010 [70].  
According to [71] the top five causes of death in children are malaria, diarrhea, 
HIV/AIDs, lower respiratory infections, and neonatal disorders. In 2015 alone, over 
212 million cases of malaria-causing 429,000 deaths were reported in Africa and the 
highest number of deaths occurred in children. Examples of lower respiratory tract 
infections are influenza, pneumonia, tuberculosis, and bronchitis Most rural areas do 
not have access to high-quality health facilities and delayed the diagnosis of these 
diseases cause it to be extremely severe. Pneumonia is the number one killer disease 
in African children and HIV/AIDS is the leading cause of deaths in African adults. 
Developing countries like Africa still have a long way to go in managing medica-
tion and adherence but the use of technology in managing drug prescription and ad-
herence is feasible, even if it is just a reminder app. An electronic prescription is an 
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effective system for measuring adherence, it can reduce the frequency of visit and 
proximity issues, and the possibility of this has been demonstrated in some simula-
tions [72, 73, 13, 74, 75] In developing countries, e-learning is also increasingly be-
coming popular, this platform can be adapted to solve some of the medication adher-
ence problems, through re-education of patients on the importance of keeping to med-
ication regimens. The remodeling of the health system into a centralized structure can 
greatly reduce cost in the long run [31], and lastly, there is a need for evidence-based 
research on the use of reminder apps and other technology in developing countries in 
order to understand the contextual issue [76]. Although the main focus of this work is 
not to design a framework, however, since total adherence is capable of catalyzing 
healing and recovery; based on the numerous factors identified in the previous sec-
tions, Fig 2 shows a few of the basic features – education, e-Prescription, and health 
care proximity – that can be achieved with using mobile technology to tackle some of 
the prevalent diseases that are already either controlled or on the decline in developed 
countries through leveraging the use of ubiquitous technology to support medication 
adherence. 
 
Fig. 2. Conceptual path to mobile adherence 
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4 Conclusion 
This paper performed a detailed review of medication adherence and ICT, the chal-
lenges and the use of varieties of technology to support patients and prescribing phy-
sicians in providing complete healthcare, with respect to intervention based on abid-
ance to medication regimens. The diseases that have received the most attention based 
on our review were identified and findings suggest that if low-income countries can 
adapt some of these technologies into managing patient’s adherence, starting with 
health education of patients’, breaking the barriers created by proximity, and cost of 
visits hospital visits, recovery from many of the prevalent diseases can be improved 
through electronic prescription and mobile reminders. Future work will explore the 
availability and evaluation of ICT solutions for endemic diseases in tropical countries. 
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